주식/증권
📉 부정적
Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway.
요약
Pfizer beats earnings forecasts for the second quarter, while BioNTech’s results miss expectations due to weak Covid vaccine demand.